This article describes and analyzes various aspects related to the neurobiology of disorganized attachment (DA), which is associated with personality, eating, affective, dissociative, and addictive disorders. We included primary studies in humans, published in PubMed from 2000 to 2022. Eight genetic and one epigenetic study were considered. Three molecular studies describe possible roles of oxytocin and cortisol, seven neurophysiological studies investigated functional correlates, and five morphological studies describe anatomical changes. Findings in candidate genes involved in dopaminergic, serotonergic, and oxytonergic systems have not been able to be replicated in large-scale human studies. Alterations in the functioning of cortisol and oxytocin are preliminary. Neurophysiological studies show changes in subcortical structures (mainly in the hippocampus) and occipital, temporal, parietal, and insular cortices. Since there is a lack of robust evidence on the neurobiology of DA in humans, the possible inferences of these studies are preliminary, which restricts their translation to clinical parameters.
{"title":"Neurobiology of Disorganized Attachment: A Review of Primary Studies on Human Beings.","authors":"Marcelo Arancibia, Mariane Lutz, Álvaro Ardiles, Camila Fuentes","doi":"10.1177/26331055221145681","DOIUrl":"https://doi.org/10.1177/26331055221145681","url":null,"abstract":"<p><p>This article describes and analyzes various aspects related to the neurobiology of disorganized attachment (DA), which is associated with personality, eating, affective, dissociative, and addictive disorders. We included primary studies in humans, published in PubMed from 2000 to 2022. Eight genetic and one epigenetic study were considered. Three molecular studies describe possible roles of oxytocin and cortisol, seven neurophysiological studies investigated functional correlates, and five morphological studies describe anatomical changes. Findings in candidate genes involved in dopaminergic, serotonergic, and oxytonergic systems have not been able to be replicated in large-scale human studies. Alterations in the functioning of cortisol and oxytocin are preliminary. Neurophysiological studies show changes in subcortical structures (mainly in the hippocampus) and occipital, temporal, parietal, and insular cortices. Since there is a lack of robust evidence on the neurobiology of DA in humans, the possible inferences of these studies are preliminary, which restricts their translation to clinical parameters.</p>","PeriodicalId":36527,"journal":{"name":"Neuroscience Insights","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/18/08/10.1177_26331055221145681.PMC9947683.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9340857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1177/26331055221146755
Alexandria Wilson, Erica M Periandri, Mackenzie Sievers, Emily Petruccelli
Repeated exposure to alcohol alters neuromolecular signaling that influences acute and long-lasting behaviors underlying Alcohol Use Disorder (AUD). Recent animal model research has implicated changes in the conserved JAK/STAT pathway, a signaling pathway classically associated with development and the innate immune system. How ethanol exposure impacts STAT signaling within neural cells is currently unclear. Here, we investigated the role of Drosophila Stat92E in ethanol-induced locomotion, signaling activity, and downstream transcriptional responses. Findings suggest that expressing Stat92E-RNAi causes enhanced ethanol-induced hyperactivity in flies previously exposed to ethanol. Furthermore, alternative splicing of Stat92E itself was detected after repeated ethanol exposure, although no changes were found in downstream transcriptional activity. This work adds to our growing understanding of altered neuromolecular signaling following ethanol exposure and suggests that STAT signaling may be a relevant target to consider for AUD treatment.
{"title":"<i>Drosophila</i> Stat92E Signaling Following Pre-exposure to Ethanol.","authors":"Alexandria Wilson, Erica M Periandri, Mackenzie Sievers, Emily Petruccelli","doi":"10.1177/26331055221146755","DOIUrl":"https://doi.org/10.1177/26331055221146755","url":null,"abstract":"<p><p>Repeated exposure to alcohol alters neuromolecular signaling that influences acute and long-lasting behaviors underlying Alcohol Use Disorder (AUD). Recent animal model research has implicated changes in the conserved JAK/STAT pathway, a signaling pathway classically associated with development and the innate immune system. How ethanol exposure impacts STAT signaling within neural cells is currently unclear. Here, we investigated the role of <i>Drosophila</i> Stat92E in ethanol-induced locomotion, signaling activity, and downstream transcriptional responses. Findings suggest that expressing <i>Stat92E-RNAi</i> causes enhanced ethanol-induced hyperactivity in flies previously exposed to ethanol. Furthermore, alternative splicing of <i>Stat92E</i> itself was detected after repeated ethanol exposure, although no changes were found in downstream transcriptional activity. This work adds to our growing understanding of altered neuromolecular signaling following ethanol exposure and suggests that STAT signaling may be a relevant target to consider for AUD treatment.</p>","PeriodicalId":36527,"journal":{"name":"Neuroscience Insights","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c2/47/10.1177_26331055221146755.PMC9834942.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10589583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1177/26331055231186993
Somnath J Gupta, Matthew A Churchward, Kathryn G Todd, Ian R Winship
Chondroitin sulfate proteoglycans (CSPGs), one of the major extracellular matrix components of the glial scar that surrounds central nervous system (CNS) injuries, are known to inhibit the regeneration of neurons. This study investigated whether pleiotrophin (PTN), a growth factor upregulated during early CNS development, can overcome the inhibition mediated by CSPGs and promote the neurite outgrowth of neurons in vitro. The data showed that a CSPG matrix inhibited the outgrowth of neurites in primary cortical neuron cultures compared to a control matrix. PTN elicited a dose-dependent increase in the neurite outgrowth even in the presence of the growth inhibitory CSPG matrix, with optimal growth at 15 ng mL-1 of PTN (114.8% of neuronal outgrowth relative to laminin control). The growth-promoting effect of PTN was blocked by inhibition of the receptor anaplastic lymphoma kinase (ALK) by alectinib in a dose-dependent manner. Neurite outgrowth in the presence of this CSPG matrix was induced by activation of the protein kinase B (AKT) pathway, a key downstream mediator of ALK activation. This study identified PTN as a dose-dependent regulator of neurite outgrowth in primary cortical neurons cultured in the presence of a CSPG matrix and identified ALK activation as a key driver of PTN-induced growth.
硫酸软骨素蛋白多糖(CSPGs)是中枢神经系统(CNS)损伤周围胶质瘢痕的主要细胞外基质成分之一,已知可抑制神经元的再生。本研究探讨了在CNS发育早期上调的生长因子多营养因子(pleiotrophin, PTN)是否能克服CSPGs介导的抑制,促进神经元的神经突生长。数据显示,与对照基质相比,CSPG基质抑制原代皮层神经元培养中神经突的生长。即使在存在生长抑制CSPG基质的情况下,PTN也引起了神经突生长的剂量依赖性增加,PTN在15 ng mL-1时的最佳生长(相对于层粘连蛋白对照,神经元生长的114.8%)。PTN的促生长作用可通过阿勒替尼抑制间变性淋巴瘤激酶(ALK)而呈剂量依赖性阻断。在这种CSPG基质存在下,神经突的生长是通过激活蛋白激酶B (AKT)途径诱导的,AKT是ALK激活的关键下游介质。本研究发现,在CSPG基质下培养的初级皮质神经元中,PTN是一种剂量依赖性的神经突生长调节剂,ALK活化是PTN诱导生长的关键驱动因素。
{"title":"Pleiotrophin Signals Through ALK Receptor to Enhance the Growth of Neurons in the Presence of Inhibitory Chondroitin Sulfate Proteoglycans.","authors":"Somnath J Gupta, Matthew A Churchward, Kathryn G Todd, Ian R Winship","doi":"10.1177/26331055231186993","DOIUrl":"https://doi.org/10.1177/26331055231186993","url":null,"abstract":"<p><p>Chondroitin sulfate proteoglycans (CSPGs), one of the major extracellular matrix components of the glial scar that surrounds central nervous system (CNS) injuries, are known to inhibit the regeneration of neurons. This study investigated whether pleiotrophin (PTN), a growth factor upregulated during early CNS development, can overcome the inhibition mediated by CSPGs and promote the neurite outgrowth of neurons in vitro. The data showed that a CSPG matrix inhibited the outgrowth of neurites in primary cortical neuron cultures compared to a control matrix. PTN elicited a dose-dependent increase in the neurite outgrowth even in the presence of the growth inhibitory CSPG matrix, with optimal growth at 15 ng mL<sup>-1</sup> of PTN (114.8% of neuronal outgrowth relative to laminin control). The growth-promoting effect of PTN was blocked by inhibition of the receptor anaplastic lymphoma kinase (ALK) by alectinib in a dose-dependent manner. Neurite outgrowth in the presence of this CSPG matrix was induced by activation of the protein kinase B (AKT) pathway, a key downstream mediator of ALK activation. This study identified PTN as a dose-dependent regulator of neurite outgrowth in primary cortical neurons cultured in the presence of a CSPG matrix and identified ALK activation as a key driver of PTN-induced growth.</p>","PeriodicalId":36527,"journal":{"name":"Neuroscience Insights","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/03/79/10.1177_26331055231186993.PMC10350765.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10665326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1177/26331055221147009
Alicia Garcia-Falgueras
Music is an art form and cultural activity whose language, the sounds and silences, is organized in time with logic and sensitivity. Music as a whole is the result of an ancestral nonverbal and international mode of human expression and communication. The primitive and former mother-child bonding might be highly influenced and modulated by the music and singing with their babies. Musicality and music imply two different sides of the same coin, where the former is based on the human capacity to produce the latter. Some theories about evolution suggest music might have an adaptive advantage for humans in society. Historical examples of different styles in music point out that if any allusion or reminder about gender in music might happen most probably occurs in folk non always written pagan or secular music with lyrics or voice. This genre of music usually tells about traditional gender differences in jobs, habits, lifestyles, etc., and has a clear preference for male musicians, while on the contrary, classical music usually does not have a clear gender difference in meaning, and instruments are played by both. In this text, I explore and empirically describe, neuroanatomically or functionally, some examples of different genres of music and brain differences, related to music and dance. Three different genres of music (Classical music, Fado and Flamenco) are explored in an attempt to elucidate some reasons for possible gender differences.
{"title":"Possible Gender Differences in Classical Music, Flamenco and Fado.","authors":"Alicia Garcia-Falgueras","doi":"10.1177/26331055221147009","DOIUrl":"https://doi.org/10.1177/26331055221147009","url":null,"abstract":"<p><p>Music is an art form and cultural activity whose language, the sounds and silences, is organized in time with logic and sensitivity. Music as a whole is the result of an ancestral nonverbal and international mode of human expression and communication. The primitive and former mother-child bonding might be highly influenced and modulated by the music and singing with their babies. Musicality and music imply two different sides of the same coin, where the former is based on the human capacity to produce the latter. Some theories about evolution suggest music might have an adaptive advantage for humans in society. Historical examples of different styles in music point out that if any allusion or reminder about gender in music might happen most probably occurs in folk non always written pagan or secular music with lyrics or voice. This genre of music usually tells about traditional gender differences in jobs, habits, lifestyles, etc., and has a clear preference for male musicians, while on the contrary, classical music usually does not have a clear gender difference in meaning, and instruments are played by both. In this text, I explore and empirically describe, neuroanatomically or functionally, some examples of different genres of music and brain differences, related to music and dance. Three different genres of music (Classical music, Fado and Flamenco) are explored in an attempt to elucidate some reasons for possible gender differences.</p>","PeriodicalId":36527,"journal":{"name":"Neuroscience Insights","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ca/2a/10.1177_26331055221147009.PMC9813978.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10513876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Recovery of motor function after peripheral nerve injury requires treatment of the neuromuscular junction (NMJ), as well as the injured nerve and skeletal muscle. The purpose of this study was to examine the effects of ultrasound (US) stimulation on NMJ degeneration after denervation using a rat model of peroneal nerve transection. Twelve-week-old male Wistar rats were randomly assigned to 3 groups: US stimulation, sham stimulation, and intact. US or sham stimulation was performed on the left tibialis anterior (TA) muscle starting the day after peroneal nerve transection for 5 minutes daily under anesthesia. Four weeks later, the number and morphology of the motor endplates were analyzed to assess NMJ in the TA muscle. The endplates were classified as normal, partially fragmented, or fully fragmented for morphometric analysis. In addition, the number of terminal Schwann cells (tSCs) per endplate and percentage of endplates with tSCs (tSC retention percentage) were calculated to evaluate the effect of tSCs on NMJs. Our results showed that endplates degenerated 4 weeks after transection, with a decrease in the normal type and an increase in the fully fragmented type in both the US and sham groups compared to the intact group. Furthermore, the US group showed significant suppression of the normal type decrease and a fully fragmented type increase compared to the sham group. These results suggest that US stimulation inhibits endplate degeneration in denervated TA muscles. In contrast, the number of endplates and tSC and tSC retention percentages were not significantly different between the US and sham groups. Further investigations are required to determine the molecular mechanisms by which US stimulation suppresses degeneration.
{"title":"Ultrasound Stimulation Inhibits Morphological Degeneration of Motor Endplates in the Denervated Skeletal Muscle of Rats.","authors":"Akira Ito, Yuki Araya, Hideki Kawai, Hiroshi Kuroki","doi":"10.1177/26331055221138508","DOIUrl":"https://doi.org/10.1177/26331055221138508","url":null,"abstract":"<p><p>Recovery of motor function after peripheral nerve injury requires treatment of the neuromuscular junction (NMJ), as well as the injured nerve and skeletal muscle. The purpose of this study was to examine the effects of ultrasound (US) stimulation on NMJ degeneration after denervation using a rat model of peroneal nerve transection. Twelve-week-old male Wistar rats were randomly assigned to 3 groups: US stimulation, sham stimulation, and intact. US or sham stimulation was performed on the left tibialis anterior (TA) muscle starting the day after peroneal nerve transection for 5 minutes daily under anesthesia. Four weeks later, the number and morphology of the motor endplates were analyzed to assess NMJ in the TA muscle. The endplates were classified as normal, partially fragmented, or fully fragmented for morphometric analysis. In addition, the number of terminal Schwann cells (tSCs) per endplate and percentage of endplates with tSCs (tSC retention percentage) were calculated to evaluate the effect of tSCs on NMJs. Our results showed that endplates degenerated 4 weeks after transection, with a decrease in the normal type and an increase in the fully fragmented type in both the US and sham groups compared to the intact group. Furthermore, the US group showed significant suppression of the normal type decrease and a fully fragmented type increase compared to the sham group. These results suggest that US stimulation inhibits endplate degeneration in denervated TA muscles. In contrast, the number of endplates and tSC and tSC retention percentages were not significantly different between the US and sham groups. Further investigations are required to determine the molecular mechanisms by which US stimulation suppresses degeneration.</p>","PeriodicalId":36527,"journal":{"name":"Neuroscience Insights","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2022-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f3/07/10.1177_26331055221138508.PMC9677316.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40481948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-26eCollection Date: 2022-01-01DOI: 10.1177/26331055221132836
Lisa M James, Apostolos P Georgopoulos
This a Reply to the Letter to the Editor by Sipila, Jussi regarding our article titled: James LM, Georgopoulos AP. High Correlations Among Worldwide Prevalences of Dementias, Parkinson's Disease, Multiple Sclerosis, and Motor Neuron Diseases Indicate Common Causative Factors. Neurosci Insights. 2022 Aug 8;17:26331055221117598. doi: 10.1177/26331055221117598.
{"title":"Reply to the Letter to the Editor by Sipila, Jussi.","authors":"Lisa M James, Apostolos P Georgopoulos","doi":"10.1177/26331055221132836","DOIUrl":"https://doi.org/10.1177/26331055221132836","url":null,"abstract":"<p><p>This a Reply to the Letter to the Editor by Sipila, Jussi regarding our article titled: James LM, Georgopoulos AP. High Correlations Among Worldwide Prevalences of Dementias, Parkinson's Disease, Multiple Sclerosis, and Motor Neuron Diseases Indicate Common Causative Factors. Neurosci Insights. 2022 Aug 8;17:26331055221117598. doi: 10.1177/26331055221117598.</p>","PeriodicalId":36527,"journal":{"name":"Neuroscience Insights","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2022-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e8/dc/10.1177_26331055221132836.PMC9623356.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40453730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-26eCollection Date: 2022-01-01DOI: 10.1177/26331055221129634
Jussi Ot Sipilä
Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). Dear Editor, I read the analysis of Worldwide Prevalences of Dementias, Parkinson’s Disease (PD), Multiple Sclerosis (MS) and Motor Neuron Diseases by James and Georgopoulos with great interest.1 This kind of epidemiological analysis is of great importance in our common quest to elucidate the causes and mechanisms of neurological diseases.2 These endeavours are all the more importance as populations age making neurodegenerative disorders increasingly common.3 However, more granular data may show previous countrylevel analyses inadequate.4 Indeed, for example in Finland the areas with high occurrence of PD, MS and Amyotrophic Lateral Sclerosis (ALS) are clearly separate: PD is most common in the middle parts of the country, with a belt of high PD incidence going across ‘the waist’ of Finland whereas MS is most common in a single Bothnian region and the southwest while ALS is most commonly found in the southeastern parts of the country.5-8 Unfortunately, no current studies on the incidence and prevalence of dementia in Finland are available. There are also marked regional differences in MS epidemiology in Norway and these do not seem to have a clear correlation with ALS rates in the country.9-12 On the other hand, Scotland’s 12 administrative regions have comparable ALS incidence whereas MS incidence shows a Southeast-Northwest gradient.13,14 It therefore seems that the conclusion concerning putative common causative factors may have been premature since regional data would be expected to show these even more clearly than country-level data. Indeed, it should also be noted that the genetic background and the effect of many already identified environmental risk factors differs between these disorders, the most obvious probably being the discrepancy between AD, MS and the smoking paradox of PD.15 The mechanisms behind these disorders are therefore also likely to differ considerably. Identifying their causes requires long-term, granular epidemiological data and direct comparisons between regions.2
{"title":"Regarding: High Correlations Among Worldwide Prevalences of Dementias, Parkinson's Disease, Multiple Sclerosis and Motor Neuron Diseases Indicate Common Causative Factors.","authors":"Jussi Ot Sipilä","doi":"10.1177/26331055221129634","DOIUrl":"https://doi.org/10.1177/26331055221129634","url":null,"abstract":"Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). Dear Editor, I read the analysis of Worldwide Prevalences of Dementias, Parkinson’s Disease (PD), Multiple Sclerosis (MS) and Motor Neuron Diseases by James and Georgopoulos with great interest.1 This kind of epidemiological analysis is of great importance in our common quest to elucidate the causes and mechanisms of neurological diseases.2 These endeavours are all the more importance as populations age making neurodegenerative disorders increasingly common.3 However, more granular data may show previous countrylevel analyses inadequate.4 Indeed, for example in Finland the areas with high occurrence of PD, MS and Amyotrophic Lateral Sclerosis (ALS) are clearly separate: PD is most common in the middle parts of the country, with a belt of high PD incidence going across ‘the waist’ of Finland whereas MS is most common in a single Bothnian region and the southwest while ALS is most commonly found in the southeastern parts of the country.5-8 Unfortunately, no current studies on the incidence and prevalence of dementia in Finland are available. There are also marked regional differences in MS epidemiology in Norway and these do not seem to have a clear correlation with ALS rates in the country.9-12 On the other hand, Scotland’s 12 administrative regions have comparable ALS incidence whereas MS incidence shows a Southeast-Northwest gradient.13,14 It therefore seems that the conclusion concerning putative common causative factors may have been premature since regional data would be expected to show these even more clearly than country-level data. Indeed, it should also be noted that the genetic background and the effect of many already identified environmental risk factors differs between these disorders, the most obvious probably being the discrepancy between AD, MS and the smoking paradox of PD.15 The mechanisms behind these disorders are therefore also likely to differ considerably. Identifying their causes requires long-term, granular epidemiological data and direct comparisons between regions.2","PeriodicalId":36527,"journal":{"name":"Neuroscience Insights","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2022-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/88/78/10.1177_26331055221129634.PMC9623354.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40453731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-17eCollection Date: 2022-01-01DOI: 10.1177/26331055221129641
Angels Almenar-Queralt, Rodrigo Dos Santos Chaves, Ester J Kwon, Sameer B Shah
Mild traumatic brain injury (mTBI), a condition in which brain function is transiently disrupted by a mechanical force, is a major risk factor for developing Alzheimer's disease (AD) and other neurodegenerative conditions. In this commentary, we summarize recent findings in human neurons derived from induced pluripotent stem cells, detailing early neuronal events following mild injury that may seed future neurodegeneration. In particular, we discuss interlinked relationships between mTBI and several biological pathways hypothesized to underlie AD progression, including amyloidogenic cleavage of amyloid precursor protein (APP), impairment of axonal transport, and the development of APP-associated axonal swellings. We also describe the implications of these findings for future mechanistic and translational studies.
{"title":"Heads Up! Interlinked Amyloidogenic and Axonal Transport Pathways in Concussion-Induced Neurodegeneration.","authors":"Angels Almenar-Queralt, Rodrigo Dos Santos Chaves, Ester J Kwon, Sameer B Shah","doi":"10.1177/26331055221129641","DOIUrl":"https://doi.org/10.1177/26331055221129641","url":null,"abstract":"<p><p>Mild traumatic brain injury (mTBI), a condition in which brain function is transiently disrupted by a mechanical force, is a major risk factor for developing Alzheimer's disease (AD) and other neurodegenerative conditions. In this commentary, we summarize recent findings in human neurons derived from induced pluripotent stem cells, detailing early neuronal events following mild injury that may seed future neurodegeneration. In particular, we discuss interlinked relationships between mTBI and several biological pathways hypothesized to underlie AD progression, including amyloidogenic cleavage of amyloid precursor protein (APP), impairment of axonal transport, and the development of APP-associated axonal swellings. We also describe the implications of these findings for future mechanistic and translational studies.</p>","PeriodicalId":36527,"journal":{"name":"Neuroscience Insights","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2022-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580075/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40566813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-09-28eCollection Date: 2022-01-01DOI: 10.1177/26331055221126179
Yukiko Hori, Youhei Sohma, Motomu Kanai, Taisuke Tomita
Alzheimer's disease (AD) is characterized by the aggregation and deposition of 2 amyloid proteins: amyloid β peptide (Aβ) and tau protein. Immunotherapies using anti-Aβ antibodies to promote the clearance of aggregated Aβ have recently been highlighted as a promising disease-modifying approach against AD. However, immunotherapy has still some problems, such as low efficiency of delivery into the brain and high costs. We have developed the "amyloid selective photo-oxygenation technology" as a comparable to immunotherapy for amyloids. The photo-oxygenation can artificially attach the oxygen atoms to specific amino acids in amyloid proteins using photocatalyst and light irradiation. We revealed that in vivo photo-oxygenation for living AD model mice reduced the aggregated Aβ in the brain. Moreover, we also showed that microglia were responsible for this promoted clearance of photo-oxygenated Aβ from the brain. These results indicated that our photo-oxygenation technology has the potential as a disease-modifying therapy against AD to promote the degradation of amyloids, resulting in being comparable to immunotherapy. Here, we introduce our technology and its effects in vivo that we showed previously in Ozawa et al., Brain, 2021, as well as a further improvement towards non-invasive in vivo photo-oxygenation described in another publication Nagashima et al., Sci. Adv., 2021, as expanded discussion.
{"title":"Promotion in the Clearance of Aggregated Aβ In Vivo Using Amyloid Selective Photo-Oxygenation Technology.","authors":"Yukiko Hori, Youhei Sohma, Motomu Kanai, Taisuke Tomita","doi":"10.1177/26331055221126179","DOIUrl":"https://doi.org/10.1177/26331055221126179","url":null,"abstract":"<p><p>Alzheimer's disease (AD) is characterized by the aggregation and deposition of 2 amyloid proteins: amyloid β peptide (Aβ) and tau protein. Immunotherapies using anti-Aβ antibodies to promote the clearance of aggregated Aβ have recently been highlighted as a promising disease-modifying approach against AD. However, immunotherapy has still some problems, such as low efficiency of delivery into the brain and high costs. We have developed the \"amyloid selective photo-oxygenation technology\" as a comparable to immunotherapy for amyloids. The photo-oxygenation can artificially attach the oxygen atoms to specific amino acids in amyloid proteins using photocatalyst and light irradiation. We revealed that in vivo photo-oxygenation for living AD model mice reduced the aggregated Aβ in the brain. Moreover, we also showed that microglia were responsible for this promoted clearance of photo-oxygenated Aβ from the brain. These results indicated that our photo-oxygenation technology has the potential as a disease-modifying therapy against AD to promote the degradation of amyloids, resulting in being comparable to immunotherapy. Here, we introduce our technology and its effects in vivo that we showed previously in Ozawa et al., <i>Brain</i>, 2021, as well as a further improvement towards non-invasive in vivo photo-oxygenation described in another publication Nagashima et al., <i>Sci. Adv.</i>, 2021, as expanded discussion.</p>","PeriodicalId":36527,"journal":{"name":"Neuroscience Insights","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2022-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e2/a5/10.1177_26331055221126179.PMC9523840.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40393419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-09-15eCollection Date: 2022-01-01DOI: 10.1177/26331055221123072
Nazaret Gamez, Rodrigo Morales
While understudied, it is suspected that peripheral Aβ peptides affect Alzheimer's disease (AD)-associated pathological changes in the brain. The peripheral sink hypothesis postulates that the central and peripheral pools of Aβ co-exist in equilibrium. As such, cerebral amyloid levels may be modulated by intervening circulating Aβ. In this commentary, we discuss relevant literature supporting the potential role of peripheral Aβ in exacerbating brain amyloidosis in both humans and mouse models of AD. Moreover, we highlight the need to further understand the mechanisms by which circulating Aβ peptides may reach the brain and contribute to neuropathology. Finally, we discuss the implications of targeting peripheral Aβ as a therapeutic approach in treating AD.
{"title":"The Role of Circulating Aβ Seeds in the Progression of Cerebral Amyloidosis.","authors":"Nazaret Gamez, Rodrigo Morales","doi":"10.1177/26331055221123072","DOIUrl":"10.1177/26331055221123072","url":null,"abstract":"<p><p>While understudied, it is suspected that peripheral Aβ peptides affect Alzheimer's disease (AD)-associated pathological changes in the brain. The peripheral sink hypothesis postulates that the central and peripheral pools of Aβ co-exist in equilibrium. As such, cerebral amyloid levels may be modulated by intervening circulating Aβ. In this commentary, we discuss relevant literature supporting the potential role of peripheral Aβ in exacerbating brain amyloidosis in both humans and mouse models of AD. Moreover, we highlight the need to further understand the mechanisms by which circulating Aβ peptides may reach the brain and contribute to neuropathology. Finally, we discuss the implications of targeting peripheral Aβ as a therapeutic approach in treating AD.</p>","PeriodicalId":36527,"journal":{"name":"Neuroscience Insights","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2022-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/31/e3/10.1177_26331055221123072.PMC9493672.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9504455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}